American Journal of Hematology

Papers
(The H4-Index of American Journal of Hematology is 45. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-07-01 to 2025-07-01.)
ArticleCitations
Issue Information498
276
Cytopenias revealing a case of carcinocythemia with bone marrow metastasis259
Aspirin use in essential thrombocythemia: Once‐daily or twice‐daily or not at all?159
Association of MPL K39N and R102P heterozygous germline mutations lead to hereditary thrombocytosis156
The evolving landscape of COVID‐19 and post‐COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative154
The insertion site is the main risk factor for central venous catheter‐related complications in patients with hematologic malignancies147
Dendritic cell vaccines extend CAR T‐cell persistence and improve the efficacy of CD19 CAR T‐cell therapy in refractory or relapsed adult B‐ALL patients135
Overall Survival in Male Patients With Advanced Hematological Disease (Mostly Acute Leukemia) Is Influenced by CYP1B1 C432G Polymorphism and Donor Sex in Allogeneic Stem Cell Transpl120
Oh node: Extranodal nodular involvement of chronic lymphocytic leukemia in the colon112
Muscular de‐conditioning and reduced cardiac inotropism due to iron deposition reduce exercise tolerance in beta thalassemia major102
Relative prognostic value of flow cytometric measurable residual disease before allogeneic hematopoietic cell transplantation for adults with MDS/AML or AML95
Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 U.S. cancer centers94
The impact of sex on platelet responses to aspirin in patients with peripheral artery disease88
Intravenous Iron Associated Hypophosphatemia: Much More Than a Laboratory Curiosity86
Not All Tryptase Elevations Are due to Acquired Clonal Mast Cell Disorders: When Tryptase Gene Copy Number Analysis Becomes Critical73
Introduction to American Journal of Hematology Supplement: Improving Initial Care for Acute GVHD Patients72
The Composite Immune Risk Score predicts overall survival after allogeneic hematopoietic stem cell transplantation: A retrospective analysis of 1838 cases71
Infections in patients with chronic lymphocytic leukemia treated with time limited targeted drug combinations71
Pediatric refractory chronic immune thrombocytopenia: Identification, patients' characteristics, and outcome68
The prognostic significance of macrocytosis in patients with myelodysplastic neoplasms68
Are veterans at increased risk of myeloproliferative neoplasms?64
Antibody response to COVID‐19 mRNA vaccine (Comirnaty) in myeloma patients treated with high‐dose melphalan and/or immunotherapy64
Secondary acquisition of the Philadelphia chromosome in acute lymphoblastic leukemia63
Hemolysis after high‐dose intravenous immunoglobulin: An under‐appreciated sequelae62
Characteristics and prevalence of antibiotic allergies in patients with sickle cell disease: A single‐center retrospective study62
Acute thrombocytopenia suggesting thrombotic microangiopathy60
Natural killer cells: Innate immune system as a part of adaptive immunotherapy in hematological malignancies58
A t(6;14;9)(p22;q22;q34) three‐way translocation: Description of a cytogenetically visible variant t(6;9) in acute myeloid leukemia57
Tocilizumab for severe acute chest syndrome in a child with sickle cell disease and dramatically high interleukin‐6 values in endotracheal and pleural fluids55
Identifying signs and symptoms of AL amyloidosis in electronic health records using natural language processing, diagnosis codes, and manually abstracted registry data55
Novel Flow Cytometric Antibody Panel and Dedicated Analysis Algorithm for Automated Fully Standardized Minimal Residual Disease Detection in Chronic Lymphocytic Leukemia55
Therapeutic Errors Associated With Antithrombotic Medications Reported to United States Poison Centers53
Comparison of the International Consensus and 5th WHO edition classifications of adult myelodysplastic syndromes and acute myeloid leukemia51
Basiliximab for steroid‐refractory acute graft‐versus‐host disease: A real‐world analysis50
Molecular and clinicopathologic characterization of pediatric histiocytoses50
Teclistamab in patients with multiple myeloma and impaired renal function50
R‐miniCHOP versus R‐CHOP in elderly patients with diffuse large B‐cell lymphoma: A propensity matched population‐based study50
The latest insights into rare blood disorders: Diagnosis and treatment strategies48
Age defining immune effector cell associated neurotoxicity syndromes in aggressive large B cell lymphoma patients treated with axicabtagene ciloleucel48
Primary Effusion Lymphoma Prognostic Score (PELPS): A Validated International Prognostic Score in HIV‐Associated Primary Effusion Lymphoma47
Table of Contents46
Clonal Hematopoiesis and Thrombosis46
45
Mini‐consolidations or intermediate‐dose cytarabine for the post‐remission therapy of AML patients over 60. A retrospective study from the DATAML and SAL registries45
Impact of Switching From Race‐Based to Race‐Neutral Spirometry Reference Equations in Children With Sickle Cell Anemia45
0.051311016082764